Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
72,061,993
-
Share change
-
-6,165,033
-
Total reported value
-
$940,730,763
-
Put/Call ratio
-
25%
-
Price per share
-
$12.94
-
Number of holders
-
282
-
Value change
-
-$86,515,524
-
Number of buys
-
115
-
Number of sells
-
156
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q2 2024
As of 30 Jun 2024,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
282 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
72,061,993 shares.
The largest 10 holders included
Capital Research Global Investors, Mondrian Investment Partners LTD, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BRANDES INVESTMENT PARTNERS, LP, FMR LLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, and VAN ECK ASSOCIATES CORP.
This page lists
281
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.